FDA Approved: CARBOPLATIN — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved a supplemental application for carboplatin filed by Apotex Corp., authorizing changes to an approved generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Small Cell Lung Cancer
• Testicular Germ Cell Tumor

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

SUPPL AP for CARBOPLATIN (CARBOPLATIN)